• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细菌微生物组在肺部疾病中的作用。

The role of the bacterial microbiome in lung disease.

机构信息

Division of Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

Expert Rev Respir Med. 2013 Jun;7(3):245-57. doi: 10.1586/ers.13.24.

DOI:10.1586/ers.13.24
PMID:23734647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4007100/
Abstract

Novel culture-independent techniques have recently demonstrated that the lower respiratory tract, historically considered sterile in health, contains diverse communities of microbes: the lung microbiome. Increasing evidence supports the concept that a distinct microbiota of the lower respiratory tract is present both in health and in various respiratory diseases, although the biological and clinical significance of these findings remains undetermined. In this article, the authors review and synthesize published reports of the lung microbiota of healthy and diseased subjects, discuss trends of microbial diversity and constitution across disease states, and look to the extrapulmonary microbiome for hypotheses and future directions for study.

摘要

最近,一些新颖的非培养技术研究表明,历史上被认为在健康状态下无菌的下呼吸道,其实含有多种多样的微生物群落:肺部微生物组。越来越多的证据支持这样一种概念,即健康人群和各种呼吸道疾病患者的下呼吸道都存在独特的微生物群,但这些发现的生物学和临床意义尚不确定。在本文中,作者对健康和患病受试者的肺部微生物组的已发表报告进行了综述和综合分析,讨论了疾病状态下微生物多样性和组成的趋势,并参考了肺外微生物组,提出了一些假说和未来的研究方向。

相似文献

1
The role of the bacterial microbiome in lung disease.细菌微生物组在肺部疾病中的作用。
Expert Rev Respir Med. 2013 Jun;7(3):245-57. doi: 10.1586/ers.13.24.
2
The microbiome in respiratory medicine: current challenges and future perspectives.呼吸医学中的微生物组:当前的挑战和未来的展望。
Eur Respir J. 2017 Apr 12;49(4). doi: 10.1183/13993003.02086-2016. Print 2017 Apr.
3
The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications.气道微生物群与慢性呼吸道疾病的新兴关系:临床意义。
Expert Rev Respir Med. 2011 Dec;5(6):809-21. doi: 10.1586/ers.11.76.
4
[The lung microbiome in 2015: a window on chronic lung diseases].《2015年的肺部微生物群:洞察慢性肺部疾病的窗口》
Med Sci (Paris). 2015 Nov;31(11):971-8. doi: 10.1051/medsci/20153111011. Epub 2015 Nov 17.
5
Microbiota: A Missing Link in The Pathogenesis of Chronic Lung Inflammatory Diseases.微生物群:慢性肺部炎症性疾病发病机制中的缺失环节。
Pol J Microbiol. 2021 Mar;70(1):25-32. doi: 10.33073/pjm-2021-013. Epub 2021 Feb 24.
6
The Human Respiratory Microbiome: Current Understandings and Future Directions.人类呼吸微生物组:当前的认识和未来的方向。
Am J Respir Cell Mol Biol. 2023 Mar;68(3):245-255. doi: 10.1165/rcmb.2022-0208TR.
7
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.囊性纤维化患者的痰液 DNA 测序:非侵入性获取肺部微生物组和病原体详情。
Microbiome. 2017 Feb 10;5(1):20. doi: 10.1186/s40168-017-0234-1.
8
Host-microbe interactions in distal airways: relevance to chronic airway diseases.远端气道中的宿主-微生物相互作用:与慢性气道疾病的相关性
Eur Respir Rev. 2015 Mar;24(135):78-91. doi: 10.1183/09059180.00011614.
9
The role of the microbiome in exacerbations of chronic lung diseases.微生物组在慢性肺部疾病恶化中的作用。
Lancet. 2014 Aug 23;384(9944):691-702. doi: 10.1016/S0140-6736(14)61136-3.
10
Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.肺部炎症和疾病:从微生物内稳态和代谢角度看。
IUBMB Life. 2019 Feb;71(2):152-165. doi: 10.1002/iub.1969. Epub 2018 Nov 22.

引用本文的文献

1
Use of Subtherapeutic Tylvalosin Against : Implications For Respiratory Microbiome Dysbiosis and Swine Lung Health.亚治疗剂量泰万菌素的使用:对呼吸道微生物群失调和猪肺部健康的影响
Transbound Emerg Dis. 2025 Aug 18;2025:8903237. doi: 10.1155/tbed/8903237. eCollection 2025.
2
Lung microbiota of patients with ARDS due to coronavirus disease 2019 receiving ECMO.接受体外膜肺氧合治疗的2019冠状病毒病所致急性呼吸窘迫综合征患者的肺部微生物群
Sci Rep. 2025 Jul 5;15(1):24068. doi: 10.1038/s41598-025-08664-1.
3
Differences of the respiratory microbiota between children suffering from community acquired pneumonia with presence or absence of asthma.

本文引用的文献

1
Comparison of the respiratory microbiome in healthy nonsmokers and smokers.健康不吸烟者和吸烟者的呼吸微生物组比较。
Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75. doi: 10.1164/rccm.201210-1913OC.
2
Longitudinal analysis of the lung microbiome in lung transplantation.肺移植中肺微生物组的纵向分析。
FEMS Microbiol Lett. 2013 Feb;339(1):57-65. doi: 10.1111/1574-6968.12053. Epub 2012 Dec 20.
3
The lung microbiome in moderate and severe chronic obstructive pulmonary disease.中重度慢性阻塞性肺疾病的肺部微生物组。
患有社区获得性肺炎且伴有或不伴有哮喘的儿童之间呼吸道微生物群的差异。
Sci Rep. 2025 Jul 1;15(1):20458. doi: 10.1038/s41598-025-04847-y.
4
Changes of respiratory microbiota associated with prognosis in pulmonary infection patients with invasive mechanical ventilation-supported respiratory failure.侵袭性机械通气支持的呼吸衰竭肺部感染患者呼吸微生物群变化与预后的关系
Ann Med. 2025 Dec;57(1):2514093. doi: 10.1080/07853890.2025.2514093. Epub 2025 Jun 9.
5
Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation.呼吸微生物群失调作为需要机械通气的社区获得性肺炎成年患者疾病严重程度的预后生物标志物。
Pneumonia (Nathan). 2025 May 5;17(1):10. doi: 10.1186/s41479-025-00163-1.
6
Post-viral lung diseases: the microbiota as a key player.病毒感染后肺部疾病:微生物群作为关键因素
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00560-2024. eCollection 2025 Mar.
7
Differences in sputum microbiota based on cure status of patients with nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者痰液微生物群基于治愈状态的差异。
Korean J Intern Med. 2025 May;40(3):449-457. doi: 10.3904/kjim.2024.209. Epub 2025 Mar 25.
8
Harnessing the Farm Effect: Microbial Products for the Treatment and Prevention of Asthma Throughout Life.利用农场效应:用于一生治疗和预防哮喘的微生物产物
Immunol Rev. 2025 Mar;330(1):e70012. doi: 10.1111/imr.70012.
9
Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota.雾化2%利多卡因对健康马的呼吸道微生物群没有可检测到的影响。
PLoS One. 2025 Jan 24;20(1):e0316079. doi: 10.1371/journal.pone.0316079. eCollection 2025.
10
The nasal mycobiome of individuals with allergic rhinitis and asthma differs from that of healthy controls in composition, structure and function.患有过敏性鼻炎和哮喘的个体的鼻腔微生物群在组成、结构和功能上与健康对照者不同。
Front Microbiol. 2024 Dec 17;15:1464257. doi: 10.3389/fmicb.2024.1464257. eCollection 2024.
PLoS One. 2012;7(10):e47305. doi: 10.1371/journal.pone.0047305. Epub 2012 Oct 11.
4
Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions.通过 Illumina 测序对囊性纤维化肺部微生物组进行分析。
PLoS One. 2012;7(10):e45791. doi: 10.1371/journal.pone.0045791. Epub 2012 Oct 2.
5
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.成人囊性纤维化气道微生物群随时间和感染类型保持稳定,并且对加重期的抗生素治疗具有高度弹性。
PLoS One. 2012;7(9):e45001. doi: 10.1371/journal.pone.0045001. Epub 2012 Sep 26.
6
Assessing bacterial populations in the lung by replicate analysis of samples from the upper and lower respiratory tracts.通过对上、下呼吸道样本的重复分析来评估肺部的细菌种群。
PLoS One. 2012;7(9):e42786. doi: 10.1371/journal.pone.0042786. Epub 2012 Sep 6.
7
Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者支气管内微生物组多样性。
J Clin Microbiol. 2012 Nov;50(11):3562-8. doi: 10.1128/JCM.00767-12. Epub 2012 Aug 22.
8
Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures.婴儿期囊性纤维化的肠道和呼吸道微生物组的序列分析:肠道和呼吸道的相互作用以及营养暴露的影响。
mBio. 2012 Aug 21;3(4). doi: 10.1128/mBio.00251-12. Print 2012.
9
Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.直接采样囊性纤维化肺组织表明,基于 DNA 的上呼吸道标本分析可能会对肺部微生物群产生误判。
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13769-74. doi: 10.1073/pnas.1107435109. Epub 2012 Aug 7.
10
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.肺移植后肺部富集的生物体和异常的细菌及真菌呼吸道微生物组。
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. doi: 10.1164/rccm.201204-0693OC. Epub 2012 Jul 12.